ORIC Pharmaceuticals, Inc.
HealthcareNASDAQ:ORIC · NASDAQ Global Select
+$0.45 today
Vol 1.56M · Avg 1.89M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-14.12%
Period High
$14.41
Period Low
$7.48
Latest
$8.27
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Terns Pharmaceuticals, Inc.
TERN
$4.77B
Enliven Therapeutics, Inc.
NASDAQ:ELVN
$2.81B
Relay Therapeutics, Inc.
NASDAQ:RLAY
$2.59B
Syndax Pharmaceuticals, Inc.
NASDAQ:SNDX
$1.62B
Atai Beckley Inc.
NASDAQ:ATAI
$1.44B
Inhibrx Biosciences, Inc.
NASDAQ:INBX
$1.35B
Precigen, Inc.
NASDAQ:PGEN
$1.34B
Tourmaline Bio, Inc.
TRML
$1.23B
Amylyx Pharmaceuticals, Inc.
NASDAQ:AMLX
$1.21B
Nektar Therapeutics
NASDAQ:NKTR
$1.16B
What is the latest ORIC filing?
The latest filing shown is SC 13G dated May 15, 2026.
How many recent filings does ORIC have?
Intrinsic Alpha currently shows 20 recent filings for ORIC.
Explore More
Continue the stock analysis
Jump to another research area for this company.